Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease
Jeong‐Yong Shin(Sungkyunkwan University), Yunjong Lee(Sungkyunkwan University), Sangwoo Ham(Samsung (South Korea)), Bina Lee(Kyung Hee University), Min Gi Jo(Gyeongsang National University), Jihun Kim(Ulsan College), Sang Won Park(Gyeongsang National University), Hyojung Kim(Samsung (South Korea)), Heejeong Kim(Samsung Medical Center), Yong Jun Kim(Deccan College Post Graduate and Research Institute), Hee‐Seok Kweon(Korea Basic Science Institute), Hye Jung Kim(Pusan National University), Seung Pil Yun(Gyeongsang National University)
Cited by 7
Related Papers
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
|Proceedings of the National Academy of Sciences|2010|282
Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage
|Proceedings of the National Academy of Sciences|2011|263